Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy
This study has been withdrawn prior to enrollment.
(Study was withdrawn due to scientific and business considerations.)
First Posted: March 16, 2012
Last Update Posted: December 29, 2015
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Estimated Primary Completion Date:||May 2017 (Final data collection date for primary outcome measure)|